#1Carmen Bergom(MCW: Medical College of Wisconsin)H-Index: 14
#2Catharine M L West(NIHR: National Institute for Health Research)H-Index: 77
Last. Wendy A. Woodward(University of Texas MD Anderson Cancer Center)H-Index: 66
view all 19 authors...
Abstract Purpose and Methods The advent of affordable and rapid next-generation DNA sequencing technology, along with the US Supreme Court ruling invalidating gene patents, has led to a deluge of germline and tumor genetic variant tests that are being rapidly incorporated into clinical cancer decision making. A major concern for clinicians is whether the presence of germline mutations may increase the risk of radiation toxicity or secondary malignancies. Since minimal clinical data exist to info...